NEKTAR THERAPEUTICS shareholders Q1 2021

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 237 filers reported holding NEKTAR THERAPEUTICS in Q1 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.

NEKTAR THERAPEUTICS shareholders Q1 2021
NameSharesValueWeighting ↓
SUSQUEHANNA INTERNATIONAL GROUP, LLP 40,958$819,0000.00%
EATON VANCE MANAGEMENT 1,702$34,0000.00%
Parkside Financial Bank & Trust 50$1,0000.00%
JANE STREET GROUP, LLC 17,544$351,0000.00%
JANE STREET GROUP, LLC 37,600$752,0000.00%
RMR Wealth Builders 67$1,0000.00%
BROWN BROTHERS HARRIMAN & CO 2,850$57,0000.00%
TCI Wealth Advisors, Inc. 26$1,0000.00%
External links

This page lists NEKTAR THERAPEUTICS's shareholders in Q1 2021. To view NEKTAR THERAPEUTICS's shareholder history, click here.